Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03253432 · ClinicalTrials.gov registry record

IN-TANDEM Familial Hypercholesterolemia Pilot Study

A clinical trial, sponsored by University of Pennsylvania.

Completed
Registry status
378
Enrollment target

NCT03253432: Completed study, sponsored by University of Pennsylvania.

NCT03253432 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 378 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03253432 has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
378 participants
Enrollment target

Study Summary

The purpose of this study is to validate the use of the FH Foundation FIND FH® Algorithm as a clinical decision support tool. FIND FH (Flag/Identify/Network/Engage) is a national initiative that utilizes machine learning and data mining techniques to identify individuals whose profiles are consistent with FH patients. The algorithm will be tested in adults with at least one cardiovascular comorbidity. Study subjects will be asked to provide either a saliva, buccal or venous blood sample for DNA and biomarker analysis

Interventions

  • OTHER Genetic testing

Trial Details

FieldValue
Enrollment Target 378 participants
Start Date 2017-07-20
Est. Completion 2018-11-07

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03253432

The ClinicalTrials.gov registry entry for NCT03253432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 378 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Genetic testing is the first listed.

NCT03253432 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03253432 about?

NCT03253432 is a clinical study titled "IN-TANDEM Familial Hypercholesterolemia Pilot Study". The purpose of this study is to validate the use of the FH Foundation FIND FH® Algorithm as a clinical decision support tool. FIND FH (Flag/Identify/Network/Engage) is a national initiative that utilizes machine learning and data mining techniques to identify individuals whose profiles are consisten...

What is the current status of trial NCT03253432?

This trial is currently completed. The enrollment target is 378 participants. The study started on 2017-07-20. Estimated completion is 2018-11-07.

What interventions are being tested in trial NCT03253432?

The interventions under investigation include: Genetic testing (OTHER).

Who is sponsoring clinical trial NCT03253432?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.